Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of South Carolina
About this trial
This pilot study will evaluate the feasibility, acceptability, and perceived usefulness of the SWITCH mobile nutrition behavioral intervention among adults receiving GLP-1 receptor agonist therapy for obesity and/or type 2 diabetes. Participants will complete baseline assessments, receive a 6-week app-based nutrition intervention consisting of daily dietary self-monitoring and weekly learning modules, and complete follow-up assessments and a structured interview.
Eligibility criteria
Qualifiers
• Age between 18 and 65 years.
BMI between 30 - 49.9 kg/m2 and/or diagnosed with type 2 diabetes.
Currently prescribed and using GLP-1 receptor therapy for at least 4 weeks.
Own a smartphone (Android or iOS) with an active data plan to support app-based intervention delivery.
Disqualifiers
• Presence of type 1 diabetes mellitus
Severe complications, including but not limited to proliferative retinopathy, severe peripheral neuropathy, nephropathy requiring dialysis, active foot ulcers, or recent hospitalization for diabetic ketoacidosis or hyperosmolar hyperglycemic state within the past 6 months.
Current or recent (within 6 months) participation in another structured weight loss program or clinical trial that may interfere with study outcomes.
Pregnancy, breastfeeding, or plans to become pregnant during the study period.
Trial design
Treatments tested in this trial
- SWITCH Diets - Mobile Nutrition Behavioral Intervention
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov